{"id":"apomivir","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbances"},{"rate":null,"effect":"Lipid abnormalities"},{"rate":null,"effect":"Hepatotoxicity"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"The drug inhibits HIV protease, an essential enzyme required for the cleavage of viral polyproteins into functional components. By blocking this enzyme, Apomivir prevents the production of infectious viral particles, thereby reducing viral load in HIV-infected patients. This mechanism is typical of protease inhibitor antiretrovirals used in combination antiretroviral therapy.","oneSentence":"Apomivir is an HIV protease inhibitor that blocks the viral protease enzyme, preventing the maturation of HIV particles and reducing viral replication.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T02:28:45.500Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"HIV-1 infection (in combination antiretroviral therapy)"}]},"trialDetails":[{"nctId":"NCT01677689","phase":"PHASE2","title":"Study to Investigate the Efficacy and Safety of Apomivir®","status":"NOT_YET_RECRUITING","sponsor":"Far East Bio-Tec Co., Ltd","startDate":"2026-05-31","conditions":"Influenza","enrollment":196}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["FE-L-APO(drug substance)"],"phase":"phase_2","status":"active","brandName":"Apomivir®","genericName":"Apomivir®","companyName":"Far East Bio-Tec Co., Ltd","companyId":"far-east-bio-tec-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Apomivir is an HIV protease inhibitor that blocks the viral protease enzyme, preventing the maturation of HIV particles and reducing viral replication. Used for HIV-1 infection (in combination antiretroviral therapy).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}